Ronald Asbury Andrews Insider Trading
Get free email notifications about insider trading for Ronald Asbury Andrews.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ronald Asbury Andrews. Ronald Asbury Andrews is a President & CEO in CLARIENT, INC ($CVSN) and a President and CEO in CLARIENT, INC ($CVSN) and a Director in Precipio, Inc. ($PRPO) and a Director in Oxford Immunotec Global PLC ($OXFD) and a CEO and President in OncoCyte Corp ($OCX) and an Chief Executive Officer in OncoCyte Corp ($OCX) and a Director in OncoCyte Corp ($OCX).
Address: 33171 PASEO CERVEZA SAN JUAN CAPISTRANO 92675 CA
Companies in which Ronald Asbury Andrews is an Insider
CLARIENT, INC
Trading Symbol: CVSNIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Ronald Asbury Andrews: President and CEO, President & CEO
Holdings: 48,000 shares
Latest Transaction: Apr 05 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OncoCyte Corp
Trading Symbol: OCXIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Ronald Asbury Andrews: CEO and President, Chief Executive Officer, Director
Holdings: 113,698 shares
Current Value: $619,654
Latest Transaction: Mar 22 2021
$OCX Market Capitalization: $159.33M
$OCX Previous Close: $5.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oxford Immunotec Global PLC
Trading Symbol: OXFDIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Ronald Asbury Andrews: Director
Holdings: 4,081 shares
Current Value: $54,481
Latest Transaction: Jun 26 2020
$OXFD Market Capitalization: $304.67M
$OXFD Previous Close: $13.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Precipio, Inc.
Trading Symbol: PRPOIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Ronald Asbury Andrews: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 04 2021
$PRPO Market Capitalization: $16.73M
$PRPO Previous Close: $0.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ronald Asbury Andrews
Sentiment: All, CVSN, OCX, OXFD, PRPO
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2021 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Buy | P | 4.79 | 11,000 | 52,702 | 113,698 | 102.7 K to 113.7 K (+10.71 %) |
Mar 04 2021 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 2.60 | 5,171 | 13,445 | 5 | |
Mar 04 2021 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 2.60 | 2,069 | 5,379 | 2,069 | |
Aug 04 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Buy | P | 1.35 | 40,000 | 53,880 | 102,698 | 62.7 K to 102.7 K (+63.80 %) |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 12.96 | 9,494 | 123,042 | 9,494 | |
Jun 26 2020 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Grant | A | 0.00 | 4,081 | 0 | 4,081 | 0 to 4.1 K |
May 12 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Option Exercise | A | 0.00 | 106,221 | 0 | 106,221 |